Status:
COMPLETED
Treatment of Mild Enteropathy Celiac Disease
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Academy of Finland
Tampere University
Conditions:
Celiac Disease
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The main purpose of this study is to evaluate the natural history of gluten sensitivity in endomysial antibody positive adults with celiac disease suspicion, who were found to have a only mild enterop...
Detailed Description
The current diagnostic criteria of celiac disease require small-bowel mucosal villous atrophy with crypt hyperplasia (Marsh III). However, the mucosal damage develops gradually and the patients may ha...
Eligibility Criteria
Inclusion
- Celiac disease suspicion
- Positive endomysial antibodies
- At least Marsh I -type small-bowel mucosal lesion
Exclusion
- Earlier celiac disease diagnosis
- Consuming oral corticosteroids or immune suppressants
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT00628823
Start Date
March 1 2003
End Date
December 1 2008
Last Update
May 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tampere
Tampere, Finland, 33014